| Literature DB >> 25105155 |
Marcos Paulo Vieira Cunha1, Maria Gabriela Xavier de Oliveira1, Mirela Caroline Vilela de Oliveira1, Ketrin Cristina da Silva2, Cleise Ribeiro Gomes2, Andrea Micke Moreno2, Terezinha Knöbl1.
Abstract
Avian Pathogenic Escherichia coli (APEC) has been studied for decades because of its economic impact on the poultry industry. Recently, the zoonotic potential of APEC and multidrug-resistant strains have emerged. The aim of this study was to characterize 225 APEC isolated from turkeys presenting airsacculitis. The results showed that 92% of strains presented a multidrug-resistance (MDR), and the highest levels of resistance were to sulfamethazine (94%) and tetracycline (83%). Half of these strains were classified in phylogenetic group B2, followed by B1 (28.6%), A (17.1%), and D (4.8%). The prevalence of virulence genes was as follows: salmochelin (iroN, 95%), increased serum survival (iss, 93%), colicin V (cvi/cva, 67%), aerobactin (iucD, 67%), temperature-sensitive haemagglutinin (tsh, 56%), iron-repressible protein (irp2, 51%), invasion brain endothelium (ibeA, 31%), vacuolating autotransporter toxin (vat, 24%), K1 antigen (neuS, 19%), enteroaggregative heat-stable cytotoxin (astA, 17%), and pilus associated with pyelonephritis (papC, 15%). These results demonstrate that the majority of the investigated strains belonged to group B2 and were MDR. These data suggest that turkeys may serve as a reservoir of pathogenic and multidrug-resistance strains, reinforcing the idea that poultry plays a role in the epidemiological chain of ExPEC.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25105155 PMCID: PMC4101927 DOI: 10.1155/2014/289024
Source DB: PubMed Journal: ScientificWorldJournal ISSN: 1537-744X
Figure 1Distribution of 225 APEC strains in relation to antibiotic resistance. NAL: nalidixic acid, ENR: enrofloxacin, NOR: norfloxacin, AMO: amoxicillin, CTX: cefotaxime, FOX: cefoxitin, TIO: ceftiofur, ERY: eritromicin, GEN: gentamycin, STR: streptomycin, FLO: florfenicol, TET: tetracycline, SXT: sulfamethoxazole/trimetropim.
Virulence and antibiotic resistance profiles in 225 strains of E. coli.
| Virulence profiles | Phylogroup ( | Total |
|---|---|---|
|
| B2 (17) | 17 (7.5) |
|
| A (12), B1 (2), B2 (2) | 16 (7.1) |
|
| A (5), B1 (5), B2 (3), D (1) | 14 (6.2) |
|
| B2 (8) | 8 (3.5) |
|
| A (3), B1 (4), B2 (1) | 8 (3.5) |
|
| A (2), B1 (4), B2 (1) | 7 (3.1) |
|
| B1 (6) | 6 (2.6) |
|
| B1 (3), B2 (1), D (1) | 5 (2.2) |
|
| B1 (4), B2 (1) | 5 (2.2) |
|
| B2 (4), D (1) | 5 (2.2 |
| Other 86 combinations | A (16), B1 (36), B2 (74), D (8) | 134 (59.5) |
|
| ||
| ≥4 genes | A (24), B1 (45), B2 (99), D (8) | 176 (78.3) |
| ≥6 genes | A (14), B1 (13), B2 (79), D (2) | 108 (48) |
| ≥8 genes | B2 (43), D (1) | 44 (19.6) |
|
| ||
| ATB resistance profiles | Phylogroup ( | Total |
|
| ||
| AMO, ERY, STR, TET, SUL, SXT | A (6), B1 (3), B2 (4) | 13 (5.7) |
| NAL, ENR, NOR, AMO, ERY, STR, TET, SUL | A (3), B1 (8), D (1) | 12 (5.3) |
| ERY, TET, SUL | A (4), B1 (3), B2 (2), D (1) | 10 (4.4) |
| NAL, AMO, ERY, STR, TET, SUL, SXT | A (1), B1 (4), B2 (4) | 9 (4) |
| ERY, SUL | B1 (1), B2 (6) | 7 (3.1) |
| NAL, ENR, NOR, AMO, ERY, STR, TET, SUL, SXT | B1 (6) | 6 (2.7) |
| AMO, ERY, STR, TET, SUL | A (1), B1 (1), B2 (4) | 6 (2.7) |
| AMO, STR, TET, SUL, SXT | B1 (2), B2 (3), D (1) | 6 (2.7) |
| ERY, STR, TET, SUL | B1 (1), B2 (4), D (1) | 6 (2.7) |
| ERY, STR, TET, SUL, SXT | A (2), B1 (1), B2 (1), D (1) | 5 (2.2) |
| Other 98 combinations | A (21), B1 (34), B2 (84), D (6) | 145 (64.5) |
|
| ||
| ≥3 ATB | A (38), B1 (62), B2 (98), D (11) | 209 (92.9) |
| ≥5 ATB | A (24), B1 (53), B2 (35), D (5) | 117 (52) |
| ≥8 ATB | A (7), B1 (20), B2 (13), D (1) | 41 (18.3) |
Distribution of 225 E. coli strains according to the phylogenetic group and presence of virulence genes.
| Group ( | Prevalence | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| A (38) | 33 (87) | 37 (97) | 27 (71) | 19 (48) | 1 (2) | 24 (63) | 15 (38) | 0 (0) | 3 (8) | 1 (2) | 5 (13) | 4.3 |
| B1 (64) | 62 (96) | 59 (92) | 38 (59) | 24 (38) | 1 (1) | 43 (67) | 14 (22) | 2 (3) | 16 (25) | 8 (12) | 8 (14) | 4.2 |
| B2 (112) | 109 (97) | 105 (93) | 81 (72) | 80 (71)∗ | 52 (46)∗ | 79 (70) | 85 (75)∗ | 40 (36)∗ | 50 (45)∗ | 24 (21) | 24 (21) | 6.5 |
| D (11) | 10 (90) | 10 (90) | 6 (54) | 5 (45) | 2 (18) | 6 (54) | 3 (27) | 1 (9) | 3 (27) | 1 (9) | 2 (18) | 4.4 |
|
| ||||||||||||
| Total (225) | 214 (95) | 211 (93) | 152 (67) | 128 (56) | 56 (24) | 152 (67) | 116 (51) | 43 (19) | 71 (31) | 34 (15) | 39 (17) | 5.4 |
*Positive association between virulence factor and phylogenetic group (P ≤ 0.05).
#VS: virulence score. A virulence score was calculated for each isolate as the sum of all virulence factors.
P value was determined using Fisher's exact test for comparisons among virulence factors and phylogenetic groups.
Distribution of virulence genes and phylogenetic groups in relation to antibiotic resistance phenotypes among 225 ExPEC isolates.
| Antibiotic | NALa | ENR | NOR | AMO | CTX | FOX | TIO | ERY | GEN | STR | FLO | TET | SXT | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Virulence factor |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ++ | |||||||||||||||||||||||||
|
| + | + | ++ | + | ++ | ++ | + | |||||||||||||||||||
|
| + | ++ | ++ | + | + | + | + | |||||||||||||||||||
|
| +c | + | + | + | + | + | + | + | + | + | ||||||||||||||||
|
| + | + | + | + | + | + | + | |||||||||||||||||||
|
| ||||||||||||||||||||||||||
|
| + | |||||||||||||||||||||||||
|
| + | |||||||||||||||||||||||||
|
| + | + | + | |||||||||||||||||||||||
|
| + | |||||||||||||||||||||||||
|
| + | + | + | + | + | + | ||||||||||||||||||||
|
| ||||||||||||||||||||||||||
| MVd (≥5 VF) | + | + | + | + | + | |||||||||||||||||||||
| Non-MV (<5) | + | + | + | + | + | |||||||||||||||||||||
|
| ||||||||||||||||||||||||||
| Phylogroup | ||||||||||||||||||||||||||
| A | + | |||||||||||||||||||||||||
| B1 | + | ++ | ++ | + | + | |||||||||||||||||||||
| B2 | ++ | ++ | + | + | + | |||||||||||||||||||||
| D | ||||||||||||||||||||||||||
|
| ||||||||||||||||||||||||||
| Virulence score | 5.5 | 5.2 | 4.3 | 5.6 | 4.1 | 5.6 | 4.9 | 5.9 | 5.4 | 5.4 | 5.7 | 5.3 | 6.6 | 5.3 | 5.3 | 5.8 | 6.7 | 5 | 5.2 | 5.6 | 6.1 | 5.3 | 5.1 | 6.5 | 4.8 | 5.7 |
aNAL: nalidixic acid, ENR: enrofloxacin, NOR: norfloxacin, AMO: amoxicillin, CTX: cefotaxime, FOX: cefoxitin, TIO: ceftiofur, ERY: erythromycin, GEN: gentamycin, STR: streptomycin, FLO: florfenicol, TET: tetracycline, SXT: sulfamethoxazole/trimetropim. Sulfamethazine is not shown in the table because it was not associated with any trait of virulence.
b R: resistant, S: susceptible.
cPositive association between traits (“+” = P < 0.05; “++” = P < 0.0001). Only statistically significant differences are shown. dMV: multivirulent.